NCT01333618

Brief Summary

It has been demonstrated that implantation of inferior vena cava filter was safe and effective in the prevention or reduction of fatal pulmonary thromboembolism in numerous clinical researches. When acute deep venous thrombosis need transcatheter thrombolysis, transfemoral Günther Tulip Filter implantation could avoid catheter across the Günther Tulip Filter. Although incidence of significant filter tilting (\>10°) is not high (13%-16%), severe tilting of the Günther Tulip Filter may be associated with difficulty or sometimes impossibility of retrieval. It has been reported that a simple technique of keeping tension of the delivery system may prevent significant tilting of the transjugular Günther Tulip Filter in an in-vitro study. But no clinical study of prevention transfemoral Günther Tulip Filter from tilting has been reported. The investigators conducted a randomized, controlled study to test whether the introducer curving technique is useful to decrease the extent of tilting of transfemoral Günther Tulip Filter.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
108

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2008

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2008

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2010

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2010

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

April 4, 2011

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 12, 2011

Completed
Last Updated

April 26, 2011

Status Verified

August 1, 2008

Enrollment Period

1.7 years

First QC Date

April 4, 2011

Last Update Submit

April 25, 2011

Conditions

Keywords

Filter TiltPreventional efficiencyGünther Tulip filterTransfemoral Approach

Outcome Measures

Primary Outcomes (1)

  • the tilting angle between the axes of Inferior Vena Cava and Günther Tulip Filter after implantation

    just after filter implantation (up to 24 hours)

Secondary Outcomes (4)

  • the tilting angle between the axes of Inferior Vena Cava and Günther Tulip Filter before retrieval

    just before filter retrieval (up to 90 days)

  • the fluoroscopy time of Günther Tulip Filter retrieval

    just after filter retrieval(up to 90 days)

  • the rate of retrieval hook adhering vascular wall

    just after filter retrieval(up to 90 days)

  • the success rate of retrieval

    just after filter retrieval(up to 90 days)

Study Arms (2)

curving introducer

EXPERIMENTAL
Device: curving introducer Günther Tulip Filter

straight introducer

PLACEBO COMPARATOR
Device: straight introducer Günther Tulip Filter

Interventions

The Günther Tulip filter (Vena Cava MReye Filter Set; William Cook Europe, Bjaeverskov, Denmark) The amplitude of introducer curvature was 5°-15° less than the angle between the inferior vena cave axis and the approached iliac vein axis and the distance between the vertex of the curved angle and the hook of the filter was 2-4cm less than the distance between the level of the renal vein confluence and the furcation of inferior vena cave.

curving introducer

The Günther Tulip filter (Vena Cava MReye Filter Set; William Cook Europe, Bjaeverskov, Denmark)

straight introducer

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • acute lower extremity deep vein thrombosis, diagnosed by vascular ultrasound and clinical history

You may not qualify if:

  • both lower extremities deep vein thrombosis
  • Inferior Vena Cava thrombosis
  • refractory hypertension (blood pressure \> 180/110mmHg)
  • contraindication of thrombolysis
  • the diameter of Inferior Vena Cava \> 35mm or \< 14mm
  • Inferior Vena Cava venous anomalies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Radiology, the First Hospital of China Medical University

Shenyang, Liaoning, 110001, China

Location

MeSH Terms

Conditions

Venous Thrombosis

Condition Hierarchy (Ancestors)

ThrombosisEmbolism and ThrombosisVascular DiseasesCardiovascular Diseases

Study Officials

  • Liang Xiao, Ph.D. M.D.

    First Hospital of China Medical University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

April 4, 2011

First Posted

April 12, 2011

Study Start

September 1, 2008

Primary Completion

June 1, 2010

Study Completion

September 1, 2010

Last Updated

April 26, 2011

Record last verified: 2008-08

Locations